Organon & Co logo

Organon (OGN) — Congressional Trading Activity

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Members Trading

3

All-time in Organon

Buyers vs Sellers

0Buyers/0Sellers

Members buying vs selling · last 90 days

Trades (90d)

0

Disclosed in the last 90 days

Avg Member Return

—

Top performers, TTM

Stock Report
$1K - $15K
StockSaleRepublicanOklahomaAug 12, 2026Aug 05, 2026House
$1K - $15K
StockSaleRepublicanOklahomaAug 10, 2026Aug 05, 2026House
$1K - $15K
StockSaleDemocratMichiganNov 24, 2025Jul 10, 2025Senate
$1K - $15K
StockSaleDemocratColoradoJul 09, 2021Jun 28, 2021Senate